Coupang Inc vs Erasca Inc. Common Stock — how do they compare? Coupang Inc trades at $15.81 (market cap $27.70B), while Erasca Inc. Common Stock trades at $15.97 (market cap $5.40B). The key difference: Coupang Inc is far larger — about 5.1× Erasca Inc. Common Stock's market cap, and Erasca Inc. Common Stock is trading nearer its 52-week high, Coupang Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Coupang Inc for 55 Days and Erasca Inc. Common Stock for 0 Days on average.
| CPNG | ERAS | |
|---|---|---|
Market Cap | $27.70B | $5.40B |
Volume | 27,703,608 | 9,533,185 |
Sector | Consumer Cyclical | Health |
52-Week High | $32.47 | $22.47 |
52-Week Low | $13.75 | $2.20 |
Typical Hold Time | 55 Days | 0 Days |
Enterprise Value | $27.22B | $5.18B |
Signals from Pluang's Aura AI — not financial advice
Coupang (CPNG) trades at $15.82, up 6.82% today, showing strong momentum despite recent earnings misses. The stock maintains a bullish technical outlook with positive moving averages and institutional support. Revenue growth remains robust at $34.53 billion for 2025, though profitability metrics show challenges with negative net income margin and ROE. Analyst consensus is strongly bullish with 87.5% buy ratings and a $25.25 price target, representing significant upside potential from current levels.
The investment case hinges on Coupang's dominant South Korean market position and expanding logistics network, but faces headwinds from inconsistent profitability and competitive pressures. While valuation appears reasonable on sales (P/S 0.8), high P/E ratio reflects earnings volatility. Key risks include execution challenges in international expansion and margin pressure from logistics investments. The stock offers growth exposure but requires careful monitoring of profitability trends.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Coupang Inc is an e-commerce company. The company sells apparel, electronics, footwear, food products, furniture, nutritional supplements, and other products. Its segments include Product Commerce and Growth Initiatives.
Read more on CPNG →Erasca is a biotechnology company developing precision medicines for cancer. Its programs target genetic drivers of tumor growth.
Read more on ERAS →